Supplement
Rose hip is the vitamin C-rich fruit left after a rose blooms, and it holds plant compounds that act as antioxidants. The evidence is limited, but skin dryness improved in a small trial of 34 people, and chemotaxis, the movement of immune cells toward inflammation, went down in a study of just eight. C-reactive protein and blood glucose showed no clear difference, and the studies were small.
Sources: PMID 17657440; PMID 21420288
- Updated
- How we grade
- 9 studies cited
- Best evidence
- Grade C
- Conditions studied
- 10
- Outcomes
- 86
- Graded outcomes
- 0029
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Chemotaxis Small Decrease | Improves (the measure goes down) | Small effect | 8 people | |||
| C-Reactive Protein (CRP) No effect | NoneNo effect | 3 studies | 8 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Pain | Improves (the measure goes down) | 2 studies | 93 people | |||
| Osteoarthritis Symptoms | Improves (the measure goes down) | 1 study | 261 people | |||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Skin Dryness Small Improvement | Improves (the measure goes up) | Small effect | 34 people | |||
| Wrinkles | Improves (the measure goes up) | 1 study | 34 people | |||
| Skin Elasticity | Improves (the measure goes up) | 34 people | ||||
Immune Health
- C-Reactive Protein (CRP)
- Chemotaxis: changes; see studies
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 3 studies | 13 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Chemotaxis | Changes; see studies | 13 people | ||||
| Liver Enzymes | Changes; see studies | 13 people | ||||
Rheumatoid Arthritis (RA)
- Anti-Oxidant Enzyme Profile
- C-Reactive Protein (CRP): improves
- Pain: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile No effect | NoneNo effect | 30 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 119 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Pain | Improves (the measure goes down) | 2 studies | 119 people | |||
| Rheumatoid Arthritis Symptoms | Improves (the measure goes down) | 119 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 89 people | ||||
| Total cholesterol | Improves (the measure goes down) | 89 people | ||||
Coronary Artery Disease (CAD)
- Adiponectin
- C-Reactive Protein (CRP): improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 31 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 31 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Glycemic Control | Improves (the measure goes up) | 1 study | 31 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Blood Pressure | Improves (the measure goes down) | 31 people | ||||
| HbA1c | Improves (the measure goes down) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 31 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Liver Enzymes | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Total cholesterol | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people | ||||
| Weight | Improves (the measure goes down) | 31 people | ||||
High Cholesterol
- Adiponectin
- C-Reactive Protein (CRP): improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 31 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 31 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Glycemic Control | Improves (the measure goes up) | 1 study | 31 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Blood Pressure | Improves (the measure goes down) | 31 people | ||||
| HbA1c | Improves (the measure goes down) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 31 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Liver Enzymes | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Total cholesterol | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people | ||||
| Weight | Improves (the measure goes down) | 31 people | ||||
Obesity
- Blood glucose
- Body Fat: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 32 people | ||||
| Body Fat | Improves (the measure goes down) | 1 study | 32 people | |||
| Blood Pressure | Improves (the measure goes down) | 32 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 32 people | ||||
| Liver Enzymes | Changes; see studies | 32 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 32 people | ||||
| Total cholesterol | Improves (the measure goes down) | 32 people | ||||
| Triglycerides | Improves (the measure goes down) | 32 people | ||||
| Weight | Improves (the measure goes down) | 32 people | ||||
Type 2 Diabetes
- Adiponectin
- C-Reactive Protein (CRP): improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 31 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 31 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Glycemic Control | Improves (the measure goes up) | 1 study | 31 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Blood Pressure | Improves (the measure goes down) | 31 people | ||||
| HbA1c | Improves (the measure goes down) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 31 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Liver Enzymes | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Total cholesterol | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people | ||||
| Weight | Improves (the measure goes down) | 31 people | ||||
Overweight
- Blood glucose
- Body Fat: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 32 people | ||||
| Body Fat | Improves (the measure goes down) | 1 study | 32 people | |||
| Blood Pressure | Improves (the measure goes down) | 32 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 32 people | ||||
| Liver Enzymes | Changes; see studies | 32 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 32 people | ||||
| Total cholesterol | Improves (the measure goes down) | 32 people | ||||
| Triglycerides | Improves (the measure goes down) | 32 people | ||||
| Weight | Improves (the measure goes down) | 32 people | ||||
Weight Loss & Maintenance
- Adiponectin
- C-Reactive Protein (CRP): improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 31 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 31 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Glycemic Control | Improves (the measure goes up) | 1 study | 31 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Blood Pressure | Improves (the measure goes down) | 31 people | ||||
| HbA1c | Improves (the measure goes down) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 31 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Liver Enzymes | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Total cholesterol | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people | ||||
| Weight | Improves (the measure goes down) | 31 people | ||||
Key findings
- ChemotaxisImproves (the measure goes down)
- Skin DrynessImproves (the measure goes up)
- C-Reactive Protein (CRP)
Shop Rose Hip
Third-party tested Rose Hip products. The evidence above is limited, so read it before you buy.
- Grade C
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
9 studies from PubMed
- The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity
- Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo
- Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons
- The effects of rose hip (Rosa canina) on plasma antioxidative activity and C-reactive protein in patients with rheumatoid arthritis and normal controls: a prospective cohort study
- Rose hip herbal remedy in patients with rheumatoid arthritis - a randomised controlled trial
- A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis--a double-blind, placebo-controlled, randomised trial
- The anti-inflammatory properties of rose-hip
- A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
- Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial